#varubi

FDA approves new drug treatment for nausea and vomiting from chemotherapy

FDA approves new drug treatment for nausea and vomiting from chemotherapy 09/02/2015 09:38 AM EDT   The U.S. Food and Drug Administration approved September 2, 2015 Release The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents)…